Wee, MD, MPH, senior deputy editor of Annals of Internal Medicine , and colleagues wrote that current evidence supports the use of lifestyle modifications potentially alongside pharmaceutical therapies among adults in whom the long-term benefits clearly outweigh the long-term risks, although the high cost of the most evidence-based therapies remains a challenge. Nevertheless, clinicians should caution against time limited use of these medications as evidence suggests weight is regained when medications are discontinued, they wrote
And lets be honest: no one wants to spend 2 AM debating whether theyre hungry or about to be sick
He et al., Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials
The anti-inflammatory properties significantly aid in the therapy of metabolic syndrome
The theoretical rationale for combining tirzepatide and orlistat centers on their complementary mechanisms, but this must be weighed against practical considerations and potential risks
The rationale behind the combination is scientifically grounded